Song Xue, Tan Shijun, He Jiafa, Lin Xiaojie, Ye Lingling, Chen Shengying, Xu Rui, Dai Yan, Chen Qianjun
Department of Breast Cancer, Guangdong Provincial Hospital of Chinese Medicine, No.111 Dade Rd, Yuexiu District, Guangzhou, 510120, Guangdong Province, China.
Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
World J Surg Oncol. 2025 Jul 22;23(1):291. doi: 10.1186/s12957-025-03925-9.
The false-negative rate (FNR) of fine needle aspiration (FNA) for clinically positive (suspicious) lymph nodes (LNs) remains excessively high.
We compared the feasibility and diagnostic efficiency of using a novel procedure to FNA for the assessment of clinically positive nodes in patients with early breast cancer. Between 1 January 2015 and 30 September 2023, 198 consecutive patients who consented to undergo axillary biopsy were referred to either the intraoperative ultrasound-guided wire localization group (IOUS-wire) or the ultrasound-guided fine needle aspiration group (US-FNAC). The primary endpoint was the false-negative rate (FNR) and accuracy rates of the two methods. One hundred patients were in the IOUS-wire group, whereas the other 98 patients were in the US-FNAC group.
The FNR of clinically positive lymph node biopsies was lower in the IOUS-wire localization group than in the US-FNAC group (16.1% versus 87.5%, p < 0.001). Among the 32 successfully identified metastatic lymph nodes, 26 (81.3%) were detected in the IOUS-wire group. In the US-FNAC group, 42 additional lymph node metastases were identified via SLNB among patients initially classified as FNAC-negative. The accuracy rates for IOUS-wire and US-FNAC were 95% and 57.1%, respectively (p < 0.001). No significant differences were observed in complications or median SLNs harvested between groups.
IOUS-wire localization with frozen sections demonstrated superior diagnostic performance compared to preoperative US-FNAC in patients with clinically node-positive early breast cancer. This novel method should be further pursued as a potential biopsy method for evaluating axillary node status, particularly in settings where rapid intraoperative decision-making is prioritized.
对于临床检查呈阳性(可疑)的淋巴结,细针穿刺活检(FNA)的假阴性率(FNR)仍然过高。
我们比较了一种新方法与FNA在评估早期乳腺癌患者临床阳性淋巴结方面的可行性和诊断效率。在2015年1月1日至2023年9月30日期间,198例连续同意接受腋窝活检的患者被分配至术中超声引导下金属丝定位组(IOUS-金属丝组)或超声引导下细针穿刺抽吸组(US-FNAC组)。主要终点是两种方法的假阴性率(FNR)和准确率。IOUS-金属丝组有100例患者,而US-FNAC组有98例患者。
IOUS-金属丝定位组临床阳性淋巴结活检的FNR低于US-FNAC组(16.1%对87.5%,p<0.001)。在32个成功识别的转移淋巴结中,IOUS-金属丝组检测到26个(81.3%)。在US-FNAC组中,最初被分类为FNAC阴性的患者中,通过前哨淋巴结活检(SLNB)又识别出42个淋巴结转移灶。IOUS-金属丝组和US-FNAC组的准确率分别为95%和57.